NCT03747003

Brief Summary

HIV infection is associated to premature decline of serum testosterone. However, prevalence and biochemical characterization of hypogonadism in HIV-infected men are still to be well defined. HIV-infection is strongly associated to erectile dysfunction in men, but preliminary data suggest that it is poorly associated with serum testosterone in this context.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
315

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 15, 2013

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2017

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

November 16, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 20, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
Last Updated

February 9, 2021

Status Verified

February 1, 2021

Enrollment Period

4.6 years

First QC Date

November 16, 2018

Last Update Submit

February 8, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Serum total testosterone

    From blood sample - unit of measurement ng/dL

    Assessed only once at the moment of enrollment with liquid chromatography tandem mass spectrometry

  • Serum total testosterone

    From blood sample - unit of measurement ng/dL

    Assessed only once at the moment of enrollment with chemiluminiscent immunoassay

Secondary Outcomes (2)

  • Serum free testosterone

    Calculated only once at the moment of enrollment

  • Score at IIEF questionnaire

    Assessed only once at the moment of enrollment

Study Arms (1)

HIV-infected male patients

Male patients (age 18-50 years) with HIV-infection and ongoing HAART therapy No intervention is provided

Other: No intervention is provided

Interventions

No intervention is provided

HIV-infected male patients

Eligibility Criteria

Age18 Years - 50 Years
Sexmale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Cohort of Young-to-Middle Aged HIV-infected Patients

You may qualify if:

  • Male gender
  • Age 18-50 years
  • HIV-infection
  • Ongoing Highly Active Antiretroviral Therapy

You may not qualify if:

  • Previous treatment with androgens, anti-androgens
  • Severe liver insufficiency
  • Severe renal insufficiency

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Azienda Ospedaliero - Universitaria di Modena

Modena, 41124, Italy

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood sample for hormonal assay

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromeEunuchismErectile Dysfunction

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesHypogonadismGonadal DisordersEndocrine System DiseasesGenital Diseases, MaleSexual Dysfunction, PhysiologicalMale Urogenital DiseasesSexual Dysfunctions, PsychologicalMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

November 16, 2018

First Posted

November 20, 2018

Study Start

May 15, 2013

Primary Completion

December 31, 2017

Study Completion

December 31, 2018

Last Updated

February 9, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

Locations